<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045212">
  <TermName>pyrazine diazohydroxide</TermName>
  <TermPronunciation>(PEER-uh-zeen dy-A-zoh-hy-DROK-side)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000730795" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pyrazine diazohydroxide&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000730794" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;diazohidróxido de pirazina&quot;" language="es" id="_4"/>
  <SpanishTermName>diazohidróxido de pirazina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del cáncer</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2005-02-15</DateLastModified>
</GlossaryTerm>
